TAFLOTAN Trademark

Trademark Overview

On Wednesday, October 5, 2005, a trademark application was filed for TAFLOTAN with the United States Patent and Trademark Office. The USPTO has given the TAFLOTAN trademark a serial number of 79016945. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, June 10, 2014. This trademark is owned by SANTEN PHARMACEUTICAL CO., LTD.. The TAFLOTAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely ophthalmic preparations for the treatment of glaucoma
taflotan

General Information

Serial Number79016945
Word MarkTAFLOTAN
Filing DateWednesday, October 5, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, June 10, 2014
Registration Number3194510
Registration DateTuesday, January 2, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely ophthalmic preparations for the treatment of glaucoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateFriday, April 13, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka-fu, Osaka 5338651
JP
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka-fu, Osaka 5338651
JP
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-fu, Osaka 5338651
JP

Trademark Events

Event DateEvent Description
Friday, December 26, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, December 26, 2014DEATH OF INTERNATIONAL REGISTRATION
Friday, February 21, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, October 30, 2013TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, December 13, 2012TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 13, 2012CANCELLED SECTION 18-TOTAL
Friday, April 13, 2012CANCELLATION TERMINATED NO. 999999
Monday, April 9, 2012CANCELLATION GRANTED NO. 999999
Friday, December 30, 2011CANCELLATION INSTITUTED NO. 999999
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 6, 2007FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 6, 2007FINAL DISPOSITION PROCESSED
Wednesday, August 1, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2006NOTICE OF PUBLICATION
Wednesday, August 30, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 28, 2006ASSIGNED TO LIE
Friday, August 4, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 26, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 26, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 4, 2006REFUSAL PROCESSED BY IB
Friday, April 14, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 14, 2006REFUSAL PROCESSED BY MPU
Wednesday, April 12, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 11, 2006NON-FINAL ACTION WRITTEN
Friday, April 7, 2006ASSIGNED TO EXAMINER
Friday, November 18, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, November 17, 2005SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

taflotan preparations glaucoma treatment namely pharmaceutical ophthalmic